← Leaderboards
Gregory O Dussor
University Of Texas Dallas
$6,397,705
Attributed
$11,471,049
Total exposure
12
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.5M · FY2011–25$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,665,685 · 13
By mechanism
U19$11,967,816 · 2
R01$8,189,618 · 4
R61$539,868 · 1
R33$534,356 · 1
R41$532,174 · 2
R56$439,180 · 1
Top collaborators
- Theodore J Price12 shared
- Scott Boitano7 shared
- Josef Vagner7 shared
- Armen N Akopian5 shared
- Benedict J Kolber4 shared
- Joseph J. Pancrazio4 shared
- Sulayman D Dib-Hajj2 shared
- Joshua J.C. Rosenthal2 shared
Most similar at University Of Texas Dallas
Same institution · by research overlap
- Benedict J Kolber$5,284,567
- Joseph J. Pancrazio$3,792,747
- Shayne Nicholas Hassler$159,703
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainLeadNeuronsMediatingMigraineAfferent NeuronsPharmacologyPlayLinkPre-ClinicalDura MaterBehaviorNovel TherapeuticsFunctional DisorderInnovationNociceptorsSignal TransductionMeningealIn VitroPathway InteractionsElectrophysiology (Science)Mast CellFaceNervous System Disorder
Grant awards (37)
Site-Directed RNA Editing of Nav1.7 as a Novel Analgesic$4,404,785
U19 · FY2025 · NS
High content analgesic screening from human nociceptors$161,669
R33 · FY2025 · AT
High content analgesic screening from human nociceptors$372,687
R33 · FY2024 · AT
High content analgesic screening from human nociceptors$169,681
R61 · FY2024 · AT
High content analgesic screening from human nociceptors$370,187
R61 · FY2023 · AT
Protease-activated-receptor-2 antagonists for treatment of migraine pain$310,351
R41 · FY2023 · NS
Meningeal prolactin signaling and female-selective migraine mechanisms$474,963
R01 · FY2022 · NS · contact PI
Site-directed RNA editing of Nav1.7 as a novel analgesic$6,789,851
U19 · FY2021 · NS
Efficacy and PK/PD Studies$773,180
U19 · FY2021 · NS · contact PI
Protease Activated Receptor Type 2 Targeting for Migraine Pain$481,084
R01 · FY2021 · NS
Meningeal prolactin signaling and female-selective migraine mechanisms$476,219
R01 · FY2021 · NS · contact PI
Protease Activated Receptor Type 2 Targeting for Migraine Pain$481,084
R01 · FY2020 · NS
Meningeal prolactin signaling and female-selective migraine mechanisms$477,461
R01 · FY2020 · NS · contact PI
Protease Activated Receptor Type 2 Targeting for Migraine Pain$481,084
R01 · FY2019 · NS
Meningeal prolactin signaling and female-selective migraine mechanisms$478,693
R01 · FY2019 · NS · contact PI
Peroxynitrite and Migraine$191,250
R21 · FY2019 · NS · contact PI
Protease Activated Receptor Type 2 Targeting for Migraine Pain$512,010
R01 · FY2018 · NS
Meningeal prolactin signaling and female-selective migraine mechanisms$493,160
R01 · FY2018 · NS · contact PI
Protease Activated Receptor Type 2 Targeting for Migraine Pain$382,151
R01 · FY2018 · NS
Peroxynitrite and Migraine$229,500
R21 · FY2018 · NS · contact PI
Non-Metal PN Scavenger/Decomposition Catalysts for Treatment of Migraine$221,823
R41 · FY2018 · NS · contact PI
Protease Activated Receptor Type 2 Targeting for Migraine Pain$494,334
R01 · FY2017 · NS
Protease Activated Receptor Type 2 Targeting for Migraine Pain$439,180
R56 · FY2016 · NS
AMPK ACTIVATORS FOR THE TREATMENT OF POST-SURGICAL PAIN$272,013
R01 · FY2016 · GM
The Role of ASICs in Migraine Pathophysiology$354,008
R01 · FY2015 · NS · contact PI
AMPK ACTIVATORS FOR THE TREATMENT OF POST-SURGICAL PAIN$273,516
R01 · FY2015 · GM
The Role of ASICs in Migraine Pathophysiology$87,819
R01 · FY2015 · NS · contact PI
The Role of ASICs in Migraine Pathophysiology$376,980
R01 · FY2014 · NS · contact PI
AMPK ACTIVATORS FOR THE TREATMENT OF POST-SURGICAL PAIN$286,815
R01 · FY2014 · GM
AMPK ACTIVATORS FOR THE TREATMENT OF POST-SURGICAL PAIN$1
R01 · FY2014 · GM
The Role of ASICs in Migraine Pathophysiology$367,613
R01 · FY2013 · NS · contact PI
AMPK ACTIVATORS FOR THE TREATMENT OF POST-SURGICAL PAIN$264,807
R01 · FY2013 · GM
The Role of ASICs in Migraine Pathophysiology$27,260
R01 · FY2013 · NS · contact PI
The Role of ASICs in Migraine Pathophysiology$326,426
R01 · FY2012 · NS · contact PI
The Role of ASICs in Migraine Pathophysiology$320,117
R01 · FY2011 · NS · contact PI
MECHANISMS OF PERIPHERALLY-MEDIATED NICOTINIC ANALGESIA$22,529
F31 · FY2002 · DA
MECHANISMS OF PERIPHERALLY-MEDIATED NICOTINIC ANALGESIA$19,394
F31 · FY2001 · DA